These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26730723)

  • 1. Omega-3 fatty acids for cystic fibrosis.
    Oliver C; Watson H
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD002201. PubMed ID: 26730723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids for cystic fibrosis.
    Oliver C; Watson H
    Cochrane Database Syst Rev; 2013 Nov; (11):CD002201. PubMed ID: 24282091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acids for cystic fibrosis.
    Oliver C; Jahnke N
    Cochrane Database Syst Rev; 2011 Aug; (8):CD002201. PubMed ID: 21833942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 fatty acids (from fish oils) for cystic fibrosis.
    McKarney C; Everard M; N'Diaye T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD002201. PubMed ID: 17943770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids (from fish oils) for cystic fibrosis.
    Beckles Willson N; Elliott TM; Everard ML
    Cochrane Database Syst Rev; 2002; (3):CD002201. PubMed ID: 12137649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HHK; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011130. PubMed ID: 29546732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral calorie supplements for cystic fibrosis.
    Smyth RL; Rayner O
    Cochrane Database Syst Rev; 2017 May; 5(5):CD000406. PubMed ID: 28470972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D supplementation for cystic fibrosis.
    Ferguson JH; Chang AB
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD007298. PubMed ID: 24823922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate supplementation in people with sickle cell disease.
    Dixit R; Nettem S; Madan SS; Soe HH; Abas AB; Vance LD; Stover PJ
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011130. PubMed ID: 26880182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug treatments for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids for cystic fibrosis.
    Balfour-Lynn IM; Welch K
    Cochrane Database Syst Rev; 2016 Aug; (8):CD001915. PubMed ID: 27552284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E supplementation in people with cystic fibrosis.
    Okebukola PO; Kansra S; Barrett J
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD009422. PubMed ID: 32892350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
    Somaraju UR; Solis-Moya A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008227. PubMed ID: 27878805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Gillies D; Sinn JKh; Lad SS; Leach MJ; Ross MJ
    Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD007986. PubMed ID: 22786509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
    Ng SM; Moore HS
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003424. PubMed ID: 33905540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled corticosteroids for cystic fibrosis.
    Balfour-Lynn IM; Welch K
    Cochrane Database Syst Rev; 2014 Oct; (10):CD001915. PubMed ID: 25300165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and oral agents for managing cystic fibrosis-related diabetes.
    Onady GM; Stolfi A
    Cochrane Database Syst Rev; 2016 Apr; 4():CD004730. PubMed ID: 27087121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin K supplementation for cystic fibrosis.
    Jagannath VA; Thaker V; Chang AB; Price AI
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD008482. PubMed ID: 32497260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.